α-Synuclein impairs macroautophagy: implications for Parkinson’s disease
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index.
Abstract
Parkinson’s disease (PD) is characterized pathologically by intraneuronal inclusions called Lewy bodies, largely comprised of α-synuclein. Multiplication of the α-synuclein gene locus increases α-synuclein expression and causes PD. Thus, overexpression of wild-type α-synuclein is toxic. In this study, we demonstrate that α-synuclein overexpression impairs macroautophagy in mammalian cells and in transgenic mice. Our data show that α-synuclein compromises autophagy via Rab1a inhibition and Rab1a overexpression rescues the autophagy defect caused by α-synuclein. Inhibition of autophagy by α-synuclein overexpression or Rab1a knockdown causes mislocalization of the autophagy protein, Atg9, and decreases omegasome formation. Rab1a, α-synuclein, and Atg9 all regulate formation of the omegasome, which marks autophagosome precursors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures





![Figure 6. α-Synuclein and Rab1a affect the colocalization of Atg9 and LC3 vesicles. (A) Endogenous immunostaining of Atg9 and p230 in SKNSH cells with α-synuclein overexpression or Rab1a knockdown. Empty GFP vector (EGFP) was used as a control for cells expressing α-synuclein–GFP. Images shown are z-stack projections. The Atg9 panels show a clear dispersal of the perinuclear localization with α-synuclein overexpression or Rab1a knockdown. Golgi fragmentation can be seen in the p230 columns. α-Synuclein overexpression causes an increase in the disorganization of the Golgi structure, a phenotype which is amplified with Rab1a knockdown. (Magnifications of these images have been deposited in the JCB DataViewer.) (B) Quantification of Atg9 colocalization with p230 (Pearson’s coefficient; ***, P < 0.001; two-tailed Student’s t test; n = 10 from one representative experiment). (C) Immunostaining of endogenous Atg9 and LC3 in cells with α-synuclein overexpression or Rab1a knockdown. Empty GFP vector (GFP) was used as a control for cells expressing α-synuclein–GFP. Colocalization is highlighted in white on merged panel (image generated by ImageJ Colocalization plugin). Images are single confocal planes to more precisely determine colocalization. Arrows denote colocalization events. (Magnifications of these images have been deposited in the JCB DataViewer.) (D and E) Quantification of Atg9 colocalization with LC3 (Pearson’s [D] and Mander’s coefficient [E]). The Mander’s coefficient shown in the first bar graph in E more accurately predicts Atg9/LC3 colocalization when LC3 vesicle number is reduced by Rab1a knockdown or α-synuclein overexpression (*, P < 0.05; **, P < 0.01; ***, P < 0.001; two-tailed Student’s t test; n = 10). (B, D, and E) Error bars represent SEM. See related Fig. S3. Bars: (A) 20 µm; (C) 10 µm.](https://figures.cochat.ai/paper-figures/72d18dd1e8114fddb91346cb34772324/synuclein-impairs-macroautophagy-implications-for-parkinsons-disease-figure-6.jpg)


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Pathologically meaningful levels of SNCA/α‐synuclein affect the intracellular localization of ATG9 via RAB1A (RAB1A, member RAS oncogene family), thereby perturbing autophagy dynamics in the brain of transgenic mice overexpressing SNCA/α‐synuclein (Winslow et al, 2010).”
From Autophagy in major human diseases (2021) · cites this paper as Winslow et al, 2010
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Conversely, overexpression of wild-type synuclein impairs autophagic activity, implying a functional relationship between synuclein and autophagic degradation19.”
From Loss of autophagy in dopaminergic neurons causes Lewy pathology and motor dysfunction in aged mice (2018) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605 · cited 2×
“Further lipidation of LC3-I creates the autophagosome-associated form, LC3-II, which is known to be a robust marker of autophagosomes (Kabeya et al., 2000).”
A guided tour into subcellular colocalization analysis in light microscopy
BOLTE, S., & CORDELIÈRES, F. P. (2006) · Journal of Microscopy · doi:10.1111/j.1365-2818.2006.01706.x · Cited by 5,324 · cited 1×
“Cells were imaged in z stacks, and images were analyzed by the JaCoP plugin (Bolte and Cordelières, 2006) in the ImageJ software.”
Cui, C., Cui, J., Jin, F., Cui, Y., Li, R., Jiang, X., Tian, Y., Wang, K., Jiang, P., & Gao, J. (2017) · Cellular Physiology and Biochemistry · doi:10.1159/000479571 · Cited by 5,203
Fission and selective fusion govern mitochondrial segregation and elimination by autophagy
Twig, G., Elorza, A., Molina, A. J. A., Mohamed, H., Wikstrom, J. D., Walzer, G., Stiles, L., Haigh, S. E., Katz, S., Las, G., et al. (2008) · The EMBO Journal · doi:10.1038/sj.emboj.7601963 · Cited by 3,082 · cited 2×
“In addition to the accumulation of aggregate-prone proteins, the cells will not be as effective in clearing dysfunctional mitochondria (Twig et al., 2008) and will have increased susceptibility to certain apoptotic insults (Ravikumar et al., 2006); these are all processes that have been implicated…”
The role of autophagy during the early neonatal starvation period
Kuma, A., Hatano, M., Matsui, M., Yamamoto, A., Nakaya, H., Yoshimori, T., Ohsumi, Y., Tokuhisa, T., & Mizushima, N. (2004) · Nature · doi:10.1038/nature03029 · Cited by 2,865
Impairment of starvation-induced and constitutive autophagy in Atg7 -deficient mice
Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., et al. (2005) · The Journal of Cell Biology · doi:10.1083/jcb.200412022 · Cited by 2,331 · cited 2×
“Mice defective for macroautophagy die soon after birth, and neuronal knockouts of such genes cause neurodegeneration accompanied by inclusion formation (Kuma et al., 2004; Komatsu et al., 2005).”
Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes
Klionsky, D. J., Abeliovich, H., Agostinis, P., Agrawal, D. K., Aliev, G., Askew, D. S., Baba, M., Baehrecke, E. H., Bahr, B. A., Ballabio, A., et al. (2008) · Autophagy · doi:10.4161/auto.5338 · Cited by 2,230 · cited 2×
“In this sense, the percentage of cells with mutant huntingtin aggregation can serve as a sensitive indicator of autophagic substrate clearance (Klionsky et al., 2008).”
Self-citationA Drosophila model of Parkinson's disease
Feany, M. B., & Bender, W. W. (2000) · Nature · doi:10.1038/35006074 · Cited by 2,118 · cited 1×
“62 (Jackson et al., 1998) with flies expressing wild-type -synuclein (UAS--syn; Feany and Bender, 2000) and with flies expressing constitutively active Rab1 (y1 P{UASp-YFP.”
Impaired Degradation of Mutant α-Synuclein by Chaperone-Mediated Autophagy
Cuervo, A. M., Stefanis, L., Fredenburg, R., Lansbury, P. T., & Sulzer, D. (2004) · Science · doi:10.1126/science.1101738 · Cited by 2,024 · cited 8×
“Vol. 190 No. 6 1023–1037 www.jcb.org/cgi/doi/10.1083/jcb.201003122 JCB 1023 Correspondence to David C. Rubinsztein: dcr1000@hermes.cam.ac.uk Abbreviations used in this paper: ANOVA, analysis of variance; CMA, chaperonemediated autophagy; HD, Huntington’s disease; PD, Parkinson’s disease; PI(3)P, phosphatidylinositol-3…”
InfluentialAxe, E. L., Walker, S. A., Manifava, M., Chandra, P., Roderick, H. L., Habermann, A., Griffiths, G., & Ktistakis, N. T. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200803137 · Cited by 1,885 · cited 2×
“Thus, cells expressing GFP-labeled DFCP1 allow for the visualization of early events in autophagosome formation (Axe et al., 2008).”
Cited by
Items 501–600 of 826
Rab11 as a modulator of synaptic transmission
Giorgini, F., & Steinert, J. R. (2013) · Communicative & Integrative Biology · doi:10.4161/cib.26807 · Cited by 21
Myöhänen, T. T., Norrbacka, S., & Savolainen, M. H. (2016) · Neuroscience Letters · doi:10.1016/j.neulet.2016.11.008 · Cited by 23
Bustamante, H. A., Cereceda, K., González, A., Valenzuela, G., Cheuquemilla, Y., Hernández, S., Arias‐Muñoz, E., Cerda‐Troncoso, C., Bandau, S., Soza, A., et al. (2020) · Cells · doi:10.3390/cells9030777 · Cited by 21
Alpha-synuclein aggresomes inhibit ciliogenesis and multiple functions of the centrosome
Iqbal, A., Baldrighi, M., Murdoch, J. N., Fleming, A., & Wilkinson, C. J. (2020) · Biology Open · doi:10.1242/bio.054338 · Cited by 21
“We sought to make aggresomes in the cells on which we performed subsequent experiments by two parallel means (Tanaka et al., 2004; Winslow et al., 2010).”
Xu, B., Huang, C., Yang, X., Li, X., Li, L., & Ding, Y. (2018) · Oncology Letters · doi:10.3892/ol.2018.7992 · Cited by 21
“Previous reports have demonstrated that RAB1A regulates the sorting of early endocytic vesicles from the endoplasmic reticulum to the Golgi complex (25) and have implicated RAB1A in Parkinson's disease (26).”
Metabolomics in Parkinson's disease
Troisi, J., Landolfi, A., Cavallo, P., Marciano, F., Barone, P., & Amboni, M. (2020) · Advances in clinical chemistry · doi:10.1016/bs.acc.2020.09.003 · Cited by 26
Neurodegenerative diseases: model organisms, pathology and autophagy
Suresh, S., Verma, V., Sateesh, S., Clement, J. P., & Manjithaya, R. R. (2018) · Journal of Genetics · doi:10.1007/s12041-018-0955-3 · Cited by 23
Ghosh, B., Karmakar, S., Prasad, M., & Mandal, A. K. (2021) · Molecular Biology of the Cell · doi:10.1091/mbc.e20-11-0747 · Cited by 22
“…or A β leads to proteasomal and autophagy impairment, which drive the cellular disruptions observed in most neurodegenerative disorders such as HD, PD, and AD (Gregori et al. , 1995; Keller et al. , 2000; McNaught and Jenner, 2001; Komatsu et al. , 2006; Winslow et al. , 2010; Hipp et al. , 2012).”
Son, S. M., Siddiqi, F. H., López, A., Ansari, R., Tyrkalska, S. D., Park, S. J., Kunath, T., Metzakopian, E., Fleming, A., & Rubinsztein, D. C. (2025) · Neuron · doi:10.1016/j.neuron.2025.03.028 · Cited by 27
“17 a -Syn overexpression or fibrils inhibit autophagy, 18 possibly through the activation of mTORC1 or by directly binding to microtubule-associated proteins 1A/1B light-chain 3B (LC3B), 19 thereby mimicking PD symptoms.”
Self-citationDu, M., Yu, Y., Wang, J., & Ji, C. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms27010366 · Cited by 27
“Notably, α -synuclein functions both as an autophagy substrate and regulator—its overexpression inhibits autophagosome formation by suppressing ATG9 localization [69].”
Mechanisms of Autoimmune Cell in DA Neuron Apoptosis of Parkinson’s Disease: Recent Advancement
Zheng, Z., Zhang, S., Zhang, H., Gao, Z., Wang, X., Liu, X., Cheng, X., Yao, L., & Lu, G. (2022) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2022/7965433 · Cited by 24
“Rab ↓ ↓/α-synuclein aggregation ↓/α-synuclein-specific T cell responses Alleviate [70, 71]”
Emerging disease‐modifying strategies targeting α‐synuclein for the treatment of Parkinson's disease
O’Hara, D. M., Kalia, S. K., & Kalia, L. V. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14345 · Cited by 27
“Overexpression of α-synuclein also causes the autophagosome formation protein Atg9 to mislocalize and thus impairs macroautophagy (Winslow et al., 2010).”
BackgroundSeranova, E., Palhegyi, A. M., Verma, S., Dimova, S., Lasry, R., Naama, M., Sun, C., Barrett, T. G., Rosenstock, T. R., Kumar, D., et al. (2020) · Journal of Molecular Biology · doi:10.1016/j.jmb.2020.01.024 · Cited by 23
“…a -synuclein Defective autophagy (by a - synuclein gene multiplication) due to impaired autophagosome formation [320,321] via ATG9 mislocalization [320] and cytoplasmic retention of TFEB [321]; defective CMA (by a - synuclein point mutations A53T or A30P) due to blockage of substrate uptake [325]…”
Visualization of Autophagy Progression by a Red–Green–Blue Autophagy Sensor
Kim, H., Kim, H., Choi, J., Inn, K., & Seong, J. (2020) · ACS Sensors · doi:10.1021/acssensors.0c00809 · Cited by 21
The role of autophagy in Parkinson's disease.
LeiZhang, Yaru, Dong, & Xiao-heng (2012) · PubMed Central · doi:10.3969/j.issn.1673-5374.2012.02.011 · Cited by 27
Endothelial Degeneration of Parkinson's Disease is Related to Alpha-Synuclein Aggregation
Yang, P., Min, X., Mohammadi, M., Turner, C. P., Faull, R. L. M., Waldvogel, H. J., Dragunow, M., & Guan, J. (2017) · Journal of Alzheimer’s Disease & Parkinsonism · doi:10.4172/2161-0460.1000370 · Cited by 20
“It has been well demonstrated that α-synuclein [26] and its associated autophagy alterations [9] and inflammation [7,27,28] contribute to the pathogenesis of neuronal degeneration of PD.”
BackgroundThe role of α-synuclein in neurodegeneration — An update
Jellinger, K. A. (2012) · Translational Neuroscience · doi:10.2478/s13380-012-0013-1 · Cited by 23
A note on testing hypotheses for stationary processes in the frequency domain
Dette, H., & Hildebrandt, T. (2011) · Journal of Multivariate Analysis · doi:10.1016/j.jmva.2011.07.002 · Cited by 22
Role of Autophagy in HIV Pathogenesis and Drug Abuse
Cao, L., Glazyrin, A. L., Kumar, S., & Kumar, A. (2016) · Molecular Neurobiology · doi:10.1007/s12035-016-0118-6 · Cited by 19
Rostami, J., Jäntti, M. H., Cui, H., Rinne, M. K., Kukkonen, J. P., Falk, A., Erlandsson, A., & Myöhänen, T. T. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110788 · Cited by 23
The significance of macroautophagy in health and disease
Tukaj, C. (2013) · Folia Morphologica · doi:10.5603/fm.2013.0015 · Cited by 22
M'angale, P. G., & Staveley, B. E. (2016) · Genetics and Molecular Research · doi:10.4238/gmr15048953 · Cited by 21
Nanomedicine against Alzheimer’s and Parkinson’s Disease
Tandon, A., Singh, S. J., & Chaturvedi, R. K. (2020) · Current Pharmaceutical Design · doi:10.2174/1381612826666201021140904 · Cited by 21
Shaikh, S., Ahmad, K., Ahmad, S. S., Lee, E. J., Lim, J. H., Beg, M. M. A., Verma, A. K., & Choi, I. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6347792 · Cited by 19
“Overexpression of α-synuclein is caused by mutations in SNCA, which encodes for α-synuclein, and these are sufficient to cause the progression of PD. Excess α-synuclein levels damage the autophagy system by hindering small GTPase Rab-1A [80].”
BackgroundInfluentialSato, Y., Terawaki, S., Oikawa, D., Shimizu, K., Okina, Y., Ito, H., & Tokunaga, F. (2023) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2023.1089213 · Cited by 18
“, 2008), α-synuclein (Winslow et al., 2010), and TDP-43 (Buchan et al.”
Qian, S., He, H., Xiong, X., Ai, R., Wang, W., Zhu, H., Ye, Q., Zhou, S., Nilsen, H. L., & Xie, C. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14532 · Cited by 19
“36 To maintain homeostasis, the body activates the PINK1/Parkin mito-phagy pathway, which leads to an increase in plasma mitochondrial protein levels.”
BackgroundVariant‐specific effects of GBA1 mutations on dopaminergic neuron proteostasis
Önal, G., Yalçın‐Çakmaklı, G., Özçelik, C. E., Boussaad, I., Şeker, U. Ö. Ş., Fernandes, H. J. R., Demır, H., Krüger, R., Elibol, B., Dökmeci, S., et al. (2024) · Journal of Neurochemistry · doi:10.1111/jnc.16114 · Cited by 21
“…literature also supports the possibility that accumulated α - synuclein in cells can disrupt various stages of the macroautophagy mechanism, such as vesicular trafficking (Winslow et al., 2010 ), cellular cytoskeleton (Sarkar et al., 2021 ), and autophagosome–lysosome fusion (Stykel et al., 2021 ).”
Rose, E. P., Osterberg, V. R., Banga, J. S., Gorbunova, V. A., & Unni, V. K. (2024) · Neurobiology of Disease · doi:10.1016/j.nbd.2024.106675 · Cited by 22
“…affecting protein degradation by the ubiquitin-proteasome system (Kumar et al., 2018; McNaught et al., 2003) or autophagy (Cuervo et al., 2004; Winslow et al., 2010; Xilouri et al., 2016). α Syn is normally localized to the presynaptic terminal and nucleus of neurons, which is how it was…”
Kim, J. H., Huh, Y. H., & Kim, H. R. (2016) · PLoS ONE · doi:10.1371/journal.pone.0153308 · Cited by 19
Accumulated α-synuclein affects the progression of GM2 gangliosidoses
Suzuki, K., Yamaguchi, A., Yamanaka, S., Kanzaki, S., Kawashima, M., Togo, T., Katsuse, O., Koumitsu, N., Aoki, N., Iseki, E., et al. (2016) · Experimental Neurology · doi:10.1016/j.expneurol.2016.07.011 · Cited by 19
Stochastics of degradation: the autophagic-lysosomal system of the cell
Kudriaeva, A. A., Av, S., & Belogurov, A. A. (2020) · Acta Naturae · doi:10.32607/actanaturae.10936 · Cited by 23
Lin, S., Leitão, A. D. G., Fang, S., Gu, Y., Barber, S., Gilliard-Telefoni, R., Castro, A., Sung, K., Shen, R., Florio, J. B., et al. (2023) · Neurobiology of Disease · doi:10.1016/j.nbd.2023.106010 · Cited by 17
“Other studies revealed that ASYN aggregates could be detrimental for the endolysosomal and macroautophay pathways, which S. Lin et al. Neurobiology of Disease 178 (2023) 106010 are involved in their clearance (Tanik et al., 2013; Winslow et al., 2010; Yan et al., 2014).”
BackgroundGawor, K., Tomé, S. O., Vandenberghe, R. R., Damme, P. V., Vandenbulcke, M., Otto, M., Arnim, C. A. F. V., Ghebremedhin, E., Ronisz, A., Ospitalieri, S., et al. (2024) · Brain Communications · doi:10.1093/braincomms/fcae442 · Cited by 26
“85,86 (ii) It has been also shown that small soluble α Syn fibrils, 200 nm in length, could be more toxic than larger aggregates.”
Spurrier, J. M., Shukla, A. K., McLinden, K. A., Johnson, K. R., & Giniger, E. (2018) · Disease Models & Mechanisms · doi:10.1242/dmm.031161 · Cited by 21
“Disrupted autophagy is strongly associated with many forms of degeneration (Hara et al., 2006; Komatsu et al., 2006; Li et al., 2008; Spencer et al., 2009; Winslow et al., 2010).”
Naz, F., Rahul, Fatima, M., Naseem, S., Khan, W., Mondal, A. C., & Siddique, Y. H. (2020) · Neuropharmacology · doi:10.1016/j.neuropharm.2020.108216 · Cited by 20
Small but mighty: Atg8s and Rabs in membrane dynamics during autophagy
Barz, S., Kriegenburg, F., Sánchez‐Martín, P., & Kraft, C. (2021) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2021.119064 · Cited by 19
Chen, S., Cai, F., Wang, J., Yang, Z., Gu, C., Wang, G., Mao, G., & Yan, J. (2019) · Molecular Medicine Reports · doi:10.3892/mmr.2019.10285 · Cited by 21
Cyclin-G-associated kinase GAK/dAux regulates autophagy initiation via ULK1/Atg1 in glia
Zhang, S., Yi, S., Wang, L., Li, S., Wang, H., Li, S., Ou, J., Zhang, M., Wang, R., Wang, M., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2301002120 · Cited by 19
Sarang, Z., Gyurina, K., Scholtz, B., Kiss, C., & Szegedi, I. (2016) · European Journal Of Haematology · doi:10.1111/ejh.12753 · Cited by 16
Ottensmeyer, J., Esch, A., Baeta, H., Sieger, S., Gupta, Y., Rathmann, M. F., Jeschke, A., Jacko, D., Schaaf, K., Schiffer, T., et al. (2024) · Current Biology · doi:10.1016/j.cub.2024.07.088 · Cited by 19
“31 40 Their regulated association with BAG3 under mechanical stress may thus facilitate membrane fusion events during CASA.”
α-Synuclein in traumatic and vascular diseases of the central nervous system
Zeng, H., Liu, N., Liu, X.-X., Yang, Y., & Zhou, M. (2020) · Aging · doi:10.18632/aging.103675 · Cited by 17
“Overexpression of WT α-Syn caused impaired macroautophagy through Rab1a inhibition [132].”
BackgroundAutophagy and Its Association with Genetic Mutations in Parkinson Disease
Erekat, N. S. (2022) · Medical Science Monitor · doi:10.12659/msm.938519 · Cited by 17
Yi, S., Wang, L., Ho, M. S., & Zhang, S. (2023) · Neural Regeneration Research · doi:10.4103/1673-5374.382259 · Cited by 14
“Interestingly, ATG9 dysregulation has been implicated in PD. α-syn overexpression causes ATG9 mislocalization and decreases omegasome (a PI3P-enriched structure on the endoplasmic reticulum where phagophores are nucleated) formation by inhibiting Rab1a (Winslow et al., 2010).”
BackgroundMethodAn Update on the Interplay between LRRK2, Rab GTPases and Parkinson’s Disease
Komori, T., & Kuwahara, T. (2023) · Biomolecules · doi:10.3390/biom13111645 · Cited by 18
Perspectives of autophagy-tethering compounds (ATTECs) in drug discovery
Ding, Y., Xing, D., Fei, Y., Luo, S., & Lu, B. (2024) · Medicine Plus · doi:10.1016/j.medp.2023.100004 · Cited by 19
Qi, L., Liu, Y., Liu, S., Xiang, L., Liu, Z., Liu, Q., Zhao, J.-Q., & Xu, X. (2024) · Phytomedicine · doi:10.1016/j.phymed.2024.155952 · Cited by 15
Canonical and noncanonical autophagy: involvement in Parkinson’s disease
Sakurai, M., & Kuwahara, T. (2025) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2025.1518991 · Cited by 17
Sirtuins and Proteolytic Systems: Implications for Pathogenesis of Synucleinopathies
Sampaio‐Marques, B., & Ludovico, P. (2015) · Biomolecules · doi:10.3390/biom5020735 · Cited by 16
Small GTPases controlling autophagy-related membrane traffic in yeast and metazoans
Takáts, S., Boda, A., Csizmadia, T., & Juhász, G. (2016) · Small GTPases · doi:10.1080/21541248.2016.1258444 · Cited by 15
Valderhaug, V. D., Heiney, K., Ramstad, O. H., Bråthen, G., Kuan, W., Nichele, S., Sandvig, A., & Sandvig, I. (2021) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00413.2020 · Cited by 13
Serrano, A., Haddad, S. E., Moal, F., Prazuck, T., Legac, É., Robin, C., Brulé, F., Charpentier, S., Normand, T., Legrand, A., et al. (2018) · AIDS · doi:10.1097/qad.0000000000001851 · Cited by 15
Deconvoluting the complexity of autophagy and Parkinson's disease for potential therapeutic purpose
Li, J., Li, S., Zhang, L., Ouyang, L., & Liu, B. (2015) · Oncotarget · doi:10.18632/oncotarget.5803 · Cited by 18
Kulkarni, P. G., Mohire, V. M., Waghmare, P. P., & Banerjee, T. (2024) · Mitochondrion · doi:10.1016/j.mito.2024.101874 · Cited by 16
Novel prospects in targeting neurodegenerative disorders via autophagy
Khan, S., Upadhyay, S., & Hassan, M. I. (2024) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2024.177060 · Cited by 16
Lee, T. V., Kaya, H. E. K., Simin, R. T., Baehrecke, E. H., & Bergmann, A. (2016) · Cell Death and Differentiation · doi:10.1038/cdd.2016.40 · Cited by 16
α -Synuclein Trafficking in Parkinson’s Disease: Insights From Fly and Mouse Models
Cheng, J., Lu, Q., Li, S., & Ho, M. S.-C. (2018) · ASN NEURO · doi:10.1177/1759091418812587 · Cited by 16
“Rab1, a regulator of ER-to-Golgi trafficking, rescues a-Syn-mediated DA neuron loss, compromised autophagy (Cooper et al., 2006; Winslow et al., 2010), and Golgi fragmentation upon a-Syn overexpression in nigral DA neurons (Coune et al., 2011; Rendon et al., 2013).”
BackgroundFluorescent Protein-Based Autophagy Biosensors
Kim, H., & Seong, J. (2021) · Materials · doi:10.3390/ma14113019 · Cited by 17
ATP13A2 and Alpha-synuclein: a Metal Taste in Autophagy
da Fonseca, T. L., & Outeiro, T. F. (2014) · Experimental Neurobiology · doi:10.5607/en.2014.23.4.314 · Cited by 15
Collins, L., Drouin‐Ouellet, J., Kuan, W., Cox, T. M., & Barker, R. A. (2017) · F1000Research · doi:10.12688/f1000research.12090.2 · Cited by 18
Fellner, L., Buchinger, E., Brück, D., Irschick, R., Wenning, G. K., & Stefanova, N. (2018) · BMC Neuroscience · doi:10.1186/s12868-018-0431-2 · Cited by 16
Gut Microbiota in Autophagy Regulation: New Therapeutic Perspective in Neurodegeneration
Mitra, S., Munni, Y. A., Dash, R., Sadhu, T., Barua, L., Islam, M. A., Chowdhury, D., Bhattacharjee, D., Mazumder, K., & Moon, I. S. (2023) · Life · doi:10.3390/life13040957 · Cited by 14
“In PD, increased alpha-synuclein levels inhibit autophagy by mislocalizing ATG9, a protein with critical functions in autophagosome formation [84].”
BackgroundCorenblum, M. J., McRobbie‐Johnson, A. C. E., Carruth, E., Bernard, K., Luo, M., Mandarino, L., Peterson, S. L., Sans-Fuentes, M. A., Billheimer, D. D., Maley, T. D., et al. (2023) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2023.102501 · Cited by 14
“On the other hand, it is known that an increased aSyn protein burden may impair autophagy and reduce the efficiency of its degradation, via mechanisms such as Rab1a inhibition and blockade of the high-mobility group box 1 protein, thus generating a bidirectional positive feedback loop (Huang et al., 2017; Winslow et a…”
BackgroundMonitoring α‐synuclein multimerization in vivo
Prasad, V., Wasser, Y., Hans, F., Goswami, A., Katona, I., Outeiro, T. F., Kahle, P. J., Schulz, J. B., & Voigt, A. (2018) · The FASEB Journal · doi:10.1096/fj.201800148rrr · Cited by 16
Aspholm, E. E., Matečko‐Burmann, I., & Burmann, B. M. (2020) · Life · doi:10.3390/life10110289 · Cited by 15
Association of ATG5 gene polymorphism with Parkinson’s disease in a Han Chinese population
Han, J., Feng, G., Wu, J., Zhang, Y., Long, Z., & Yao, X. (2021) · Acta Neurologica Belgica · doi:10.1007/s13760-021-01814-y · Cited by 14
Parkinson’s disease physiopathology—beyond the α-synuclein aggregation: a narrative review
Macêdo, V. F. B., Macedo, V. K. B., Coelho, J. A. P. D. M., & Barboza, A. M. D. M. (2025) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2025.1664269 · Cited by 19
Viral alpha-synuclein knockdown prevents spreading synucleinopathy
Menon, S. A., Kofoed, R. H., Nabbouh, F., Xhima, K., Al-Fahoum, Y., Langman, T., Mount, H. T. J., Shihabuddin, L. S., Sardi, S. P., Fraser, P. E., et al. (2021) · Brain Communications · doi:10.1093/braincomms/fcab247 · Cited by 17
Cui, J., Yu, Y., Wang, J., Song, N., & Xie, J. (2022) · Molecular Neurobiology · doi:10.1007/s12035-021-02687-1 · Cited by 12
“It is well documented that both α-synuclein over-expression and α-synuclein PFFs treatment act as autophagy inhibitor, hindering the formation and clearance of autophagosomes [75, 76].”
BackgroundMicroRNAs regulating autophagy: opportunities in treating neurodegenerative diseases
Mohseni, M., Behzad, G., Farhadi, A., Behroozi, J., Mohseni, H., & Valipour, B. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1397106 · Cited by 14
PLK2 disrupts autophagic flux to promote SNCA/α-synuclein pathology
Zhang, C., Huang, Z.-P., Huang, X., Ma, Y., Cao, Y., Zhang, Z., Wang, R., Ren, H., Zheng, L. T., Liu, C.-F., et al. (2025) · Autophagy · doi:10.1080/15548627.2024.2448914 · Cited by 16
“The overexpression of SNCA compromises the RAB1A-specific secretory pathway and interferes with the location of the autophagy protein ATG9 in the trans-Golgi network, hindering autophagosome formation [66].”
Eteläinen, T. S., Kilpeläinen, T. P., Ignatius, A., Auno, S., Lorenzo, F. D., Uhari-Väänänen, J. K., Julku, U. H., & Myöhänen, T. T. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109213 · Cited by 13
Crosstalk between the Rho and Rab family of small GTPases in neurodegenerative disorders
Akhtar, S. N., Bunner, W., Brennan, E., Lu, Q., & Szatmari, E. M. (2023) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2023.1084769 · Cited by 18
“Moreover, in a rodent model of PD, increasing Rab1 expression reduces α-synuclein-mediated Golgi fragmentation, prevents the death of dopaminergic neurons, and ameliorates PD-like motor deficits (Winslow et al., 2010).”
Background“Janus-Faced” α-Synuclein: Role in Parkinson’s Disease
Ray, B., Mahalakshmi, A. M., Tuladhar, S., Bhat, A., Srinivasan, A., Pellegrino, C., Kannan, A., Bolla, S. R., Chidambaram, S. B., & Sakharkar, M. K. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.673395 · Cited by 18
Examining the Toxicity of α-Synuclein in Neurodegenerative Disorders
Shan, F. Y., Fung, K., Zieneldien, T., Kim, J., Cao, C., & Huang, J. H. (2021) · Life · doi:10.3390/life11111126 · Cited by 13
Jiang, T., & Chen, S. (2012) · Neuroscience Bulletin · doi:10.1007/s12264-012-1263-1 · Cited by 12
α-Synuclein in Parkinson's Disease: 12 Years Later
Vekrellis, K., Emmanouilidou, E., Xilouri, M., & Stefanis, L. (2024) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a041645 · Cited by 16
Niederberger, E., Möller, M., Mungo, E., Haß, M., Wilken‐Schmitz, A., Manderscheid, C., Möser, C. V., & Geißlinger, G. (2023) · The FASEB Journal · doi:10.1096/fj.202301489r · Cited by 13
Autophagy Dysfunction and Neurodegeneration: Where Does It Go Wrong?
Oettinger, D., & Yamamoto, A. (2025) · Journal of Molecular Biology · doi:10.1016/j.jmb.2025.169219 · Cited by 11
Linking membrane dynamics and trafficking to autophagy and the unfolded protein response
Chua, C. E. L., & Tang, B. L. (2013) · Journal of Cellular Physiology · doi:10.1002/jcp.24341 · Cited by 11
“It is well known that toxic forms of a-synuclein induces UPR (Bellucci et al., 2011; Colla et al., 2012) and suppresses autophagy (Winslow et al., 2010; Winslow and Rubinsztein, 2011).”
BackgroundFriesen, E. L., Zhang, Y. T., Earnshaw, R., de Snoo, M. L., O’Hara, D. M., Agapova, V., Chau, H., Ngana, S. G., Chen, K. S., Kalia, L. V., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00716 · Cited by 14
“…mitophagy (De Snoo et al., 2019), it may also be possible that BAG5 has a downstream inhibitory effect on autophagic flux, which, in turn, slows the degradation of p62 and alpha-synuclein via the ALP and promotes the accumulation of p62 and alpha-synuclein aggregates (Wu et al., 2015).”
BackgroundSánchez-Vidaña, D. I., Li, J., Abokyi, S., Chan, J. N.-M., Ngai, S. P. C., & Lau, B. W.-M. (2023) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2023.1168948 · Cited by 12
Muneeb, M., Abdallah, D. M., El-Abhar, H. S., Wadie, W., Ahmed, K. A., & Fadl, Y. S. A. (2025) · Neuropharmacology · doi:10.1016/j.neuropharm.2025.110346 · Cited by 11
Inoue, S., Nishimura, K., Gima, S., Nakano, M., & Takata, K. (2023) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b22-00839 · Cited by 10
Ca2+ signalling: A common language for organelles crosstalk in Parkinson's disease
Peggion, C., Barazzuol, L., Poggio, E., Calí, T., & Brini, M. (2023) · Cell Calcium · doi:10.1016/j.ceca.2023.102783 · Cited by 11
Silencing of SIAH1 in SH-SY5Y affects α-synuclein degradation pathway.
Xu, J., Zhang, X.-Z., Zhang, Y.-J., Li, X.-M., Cai, Z., & Li, X. (2015) · PubMed Central · Cited by 10
Roy, A., Rangasamy, S. B., Kundu, M., & Pahan, K. (2016) · Scientific Reports · doi:10.1038/srep22067 · Cited by 11
Chen, Y., Zhang, N., Ji, D., Hou, Y., Chen, C., Fu, Y., Ge, R., Zheng, Q., Chen, J., & Wang, H. (2018) · Neuroreport · doi:10.1097/wnr.0000000000001097 · Cited by 10
Self-citationFu, C., Yang, N., Chuang, J.-Z., Nakajima, N., Iraha, S., Roy, N. S., Wu, Z., Jiang, Z., Otsu, W., Radu, R. A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-50189-0 · Cited by 10
Pan, Y., Chen, M., Pan, L., Tong, Q., Cheng, Z., Lin, S., Pan, R., Chen, M., & Zhi, Y. (2024) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s476969 · Cited by 10
“5 Autophagy begins with the formation of nascent autophagosomal vacuoles or isolation membranes.”
BackgroundCannabidiol induces autophagy via CB1 receptor and reduces α-synuclein cytosolic levels
Erustes, A. G., Abílio, V. C., Bincoletto, C., Piacentini, M., Pereira, G. J. S., & Smaili, S. S. (2024) · Brain Research · doi:10.1016/j.brainres.2024.149414 · Cited by 11
“…reticulum (ER), the nucleus and membranes (Auluck et al., 2010; Br ´ as et al., 2020), where it can affect cellular Ca 2 + homeostasis and oxidative stress, which leads to mitochondrial dysfunction, and consequently, neuronal cell death (Hsu et al., 2000; Wang et al., 2019; Winslow et al., 2010).”
Zhang, S., Wang, L., Yi, S., Tsai, Y.-T., Cheng, Y.-H., Lin, Y.-T., Lin, C.-C., Lee, Y., Wang, H., Li, S., et al. (2025) · Autophagy · doi:10.1080/15548627.2024.2442858 · Cited by 12
How does autophagy impact neurological function?
Fleming, A., López, A., Rob, M., Ramakrishna, S., Park, S. J., Li, X., & Rubinsztein, D. C. (2025) · The Neuroscientist · doi:10.1177/10738584251324459 · Cited by 11
Self-citationAn Emerging Role for Phosphoinositides in the Pathophysiology of Parkinson’s Disease
Schechter, M., & Sharon, R. (2021) · Journal of Parkinson s Disease · doi:10.3233/jpd-212684 · Cited by 11
“However, other studies have reported evidence showing an inhibitory role for -Syn in autophagosome formation and macroautophagy [170, 171].”
BackgroundAutophagy at the synapse, an early site of dysfunction in neurodegeneration
Jasutkar, H. G., & Yamamoto, A. (2023) · Current Opinion in Physiology · doi:10.1016/j.cophys.2023.100631 · Cited by 10
Gao, M., Xiao, H., Liang, Y., Cai, H., Guo, X., Lin, J., Zhuang, S., Xu, J., & Ye, S. (2023) · Molecular & Cellular Proteomics · doi:10.1016/j.mcpro.2023.100628 · Cited by 9
“Evidence suggests that SNCA may also induce productive autophagy in neurons (16, 17), impair early stages of autophagosome formation (18, 19), and enhance autophagic flux (20).”
BackgroundLi, S., & Le, W. (2017) · Science China Life Sciences · doi:10.1007/s11427-017-9214-7 · Cited by 8
Soe, K. K., Beard, H., Neumann, D., Trim, P. J., Duplock, S. K., Snel, M. F., Hopwood, J. J., & Hemsley, K. M. (2019) · Neuropathology and Applied Neurobiology · doi:10.1111/nan.12548 · Cited by 9
Loss of MINAR2 impairs motor function and causes Parkinson’s disease-like symptoms in mice
Ho, R., Amraei, R., Cena, K. D. L. D. L., Sutherland, E. G., Mortazavi, F., Stein, T., Chitalia, V., & Rahimi, N. (2020) · Brain Communications · doi:10.1093/braincomms/fcaa047 · Cited by 7
“Under pathological conditions, the failure in these systems contributes to its toxicity and accumulation in cells leading to ER stress(Chu et al., 2009; Winslow et al., 2010; Decressac and Bjorklund, 2013).”
BackgroundRaj, E. N., Lin, Y., Chen, C., Liu, K., & Chao, J. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000085 · Cited by 10
Self-citationDrosophila as a model to study autophagy in neurodegenerative diseases and digestive tract
Tzou, F., Wen, J., Yeh, J., Huang, S., Chen, G., & Chan, C. (2021) · IUBMB Life · doi:10.1002/iub.2583 · Cited by 11
Metadata
- Authors
- Winslow, A. R., Chen, C.-W., Corrochano, S., Acevedo-Arozena, A., Gordon, D. E., Peden, A. A., Lichtenberg, M., Menzies, F. M., Ravikumar, B., Imarisio, S., Brown, S., O’Kane, C. J., & Rubinsztein, D. C.
- Affiliations
- University of Cambridge (GB)
- Medical Research Council (GB)
- Mammalian Genetics Unit, Medical Research Council Harwell, Oxfordshire OX11 0RD, England, UK 4
- Corresponding author
- Rubinsztein, David C.
- ORCID
- Venue
- Journal of Cell Biology
- Publisher
- Rockefeller University Press
- Published
- 2010-09-20
- Volume
- 190
- Issue
- 6
- Pages
- 1023-1037
- ISSN
- 0021-9525 (ISSN-L)
- 1540-8140
- PMC
- PMC3101586
- OpenAlex
- W2142047537
- Cited by
- 825
- References
- 51
- Citations by year
- 2026: 36 · 2025: 41 · 2024: 55 · 2023: 45 · 2022: 42 · 2021: 51 · 2020: 66 · 2019: 72 · 2018: 57 · 2017: 66 · 2016: 65 · 2015: 53 · 2014: 37 · 2013: 43 · 2012: 51
- FWCI
- 26.49
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- Locations
- The Journal of Cell Biology (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- Funders
- Wellcome Trust (FP7/2007–2013, 089703)
- European Commission (241791)
- Cambridge Trust
- Medical Research Council (MC_G1000734)
- Topics
- Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Autophagy in Disease and Therapy
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Keywords
- alpha-synuclein, macroautophagy, Parkinson's disease, Rab1A, Atg9, Lewy bodies, transgenic mice
- MeSH terms
- Animals, Autophagy, Drosophila melanogaster, Golgi Apparatus, Humans, Membrane Proteins, Microtubule-Associated Proteins, Models, Biological, Parkinson Disease, Phagosomes, rab1 GTP-Binding Proteins, Protein Transport, Secretory Vesicles, Cell Line, Tumor, Mice, alpha-Synuclein, Gene Knockdown Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.